F07 Indications and Evidence for Neuromodulation

3:30 PM - 5:00 PM Friday, July 16

This session is designed for residents and fellows. It will address several unique aspects of neuromodulation. It will focus on the use of neuromodulation specific for headaches. In addition, it will focus on the role of IDDS as well as PNS as analgesic therapies.

CME Credits: 1.5 AMA PRA Category 1 CreditsTM

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Discuss indications of neuromodulation for headaches.
  • Describe an evidence-based approach to IDDS trials, including the NACC guidelines.
  • Explain the evidence supporting peripheral nerve stimulation as an analgesic therapy.


Timothy R. Lubenow, MD

Preet Patel, MD

Neuromodulation for Headache

Samer Narouze, MD, PhD

Indications for SCS and PNS

David Spinner, DO

Programming: What Do I Need to Know?

Ellen L. Air, MD, PhD

Pumps: Let's Talk About Trials

Tammy L. Dann, DO,MPH

Faculty and Presentations subject to change.